Recruiting Angelman Syndrome Studies in Los Angeles
About Angelman Syndrome Clinical Trials in Los Angeles
Angelman syndrome is a rare genetic disorder primarily affecting the nervous system, characterized by severe developmental delays, speech impairment, seizures, and a happy demeanor. It is caused by loss of function of the UBE3A gene. Treatment focuses on managing symptoms and maximizing developmental potential.
There are currently 2 angelman syndrome clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 312 participants. Research is being sponsored by Boston Children's Hospital, MavriX Bio, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Angelman Syndrome Clinical Trials in Los Angeles — FAQ
Are there angelman syndrome clinical trials in Los Angeles?
Yes, there are 2 angelman syndrome clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What angelman syndrome treatments are being tested?
The 2 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for angelman syndrome.
Data updated October 12, 2026 from ClinicalTrials.gov